JenniferR(Miller)BrownMD

PubMed

• 2 citations
  Reducing Readmission of Hospitalized Patients With Depressive Symptoms: A Randomized Trial.
  Suzanne E Mitchell, Matthew Reichert, Jessica Martin Howard, Katherine Krizman, Alexa Bragg, Molly Huffaker, Kimberly Parker, Mary Cawley, Hannah Webb Roberts, Yena Su...> ;Annals of Family Medicine. 2022 May 23
• 52 citations
  Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, ph...
  Matthew S. Davids, Danielle M. Brander, Haesook T. Kim, Svitlana Tyekucheva, Alexandra Savell, Jeffrey M Hellman, Josie Bazemore, Karen Francoeur, Alvaro J. Alencar, L...> ;The Lancet. Haematology. 2019 Aug 1
• 7 citations
  Durable remissions with obinutuzumab-based chemoimmunotherapy: long-term follow-up of the phase 1b GALTON trial in CLL
  Jennifer R. Brown, Susan O'Brien, C. Daniel Kingsley, Herbert Eradat, John M. Pagel, Jamie Hirata, Tammy McIver, Rodica Morariu-Zamfir, Thomas J. Kipps> ;Blood. 2019 Feb 28
• 68 citations
  Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis.
  Jennifer R. Brown, Javid Moslehi, Michael S. Ewer, Susan O'Brien, Paolo Ghia, Florence Cymbalista, Tait D. Shanafelt, Graeme Fraser, Simon Rule, Steven Coutre, Marie S...> ;British Journal of Haematology. 2019 Feb 1
• 3 citations
  DUO delivers for duvelisib.
  Jennifer R. Brown> ;Blood. 2018 Dec 6
• 80 citations
  Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia.
  Christopher J. Ott, Alexander J. Federation, Logan Schwartz, Siddha Kasar, Josephine L. Klitgaard, Romina E. Lenci, Qiyuan Li, Matthew A. Lawlor, Stacey M. Fernandes, ...> ;Cancer Cell. 2018 Dec 10
• 12 citations
  Relapsed CLL: sequencing, combinations, and novel agents.
  Jennifer R. Brown> ;Hematology. American Society of Hematology. Education Program. 2018 Nov 30
• 566 citations
  Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL
  Jennifer A. Woyach, Amy S. Ruppert, Nyla A. Heerema, Weiqiang Zhao, Allison M Booth, Wei Ding, Nancy L. Bartlett, Danielle M. Brander, Paul M. Barr, Kerry A. Rogers, S...> ;The New England Journal of Medicine. 2018 Dec 1
• 28 citations
  Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients Wit...
  Jacqueline C. Barrientos, Susan O'Brien, Jennifer R. Brown, Neil E. Kay, Nishitha Reddy, Steven Coutre, Constantine S. Tam, Stephen P. Mulligan, Ulrich Jaeger, Stephen...> ;Clinical Lymphoma, Myeloma & Leukemia. 2018 Dec 1
• 2 citations
  Vigilance for ibrutinib-associated ventricular arrhythmias: rare but be aware.
  Constantine S. Tam, Jennifer R. Brown> ;Leukemia & Lymphoma. 2018 Jul 22
• Voxtalisib (XL765) in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukaemia: An Open-Label, Phase 2 Trial
  Joanne J Lager, Jennifer R Brown, Nashat Y Gabrail, Siddhartha Ganguly, Nina Wagner-Johnston, Michael Millenson> ;The Lancet.
• 187 citations
  Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL
  Jennifer R. Brown, Peter Hillmen, Susan O'Brien, Jaqueline C. Barrientos, Nishitha Reddy, S. E. Coutre, Constantine S. Tam, Stephen P. Mulligan, Ulrich Jaeger, Paul M....> ;Leukemia. 2018 Jan 1
• Analysis of ITGB2 Rare Germline Variants in Chronic Lymphocytic Leukemia
  Jennifer (Miller) Brown, MD> ;Blood. 2017 Oct 21
• 28 citations
  Rare Germline Variants in ATM Are Associated with Chronic Lymphocytic Leukemia
  Grace Tiao, Ma. Reina Improgo, Siddha Kasar, Weijie Poh, Atanas Kamburov, Dan-Avi Landau, Eugen Tausch, Amaro Taylor-Weiner, Carrie Cibulskis, Samira Bahl, Stacey M. F...> ;Leukemia. 2017 Jun 27
• 24 citations
  Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia
  Elizabeth Murphy, Donna Neuberg, Laura Z. Rassenti, Gregory M. Hayes, Robert A. Redd, Claire L. Emson, K Li, Jennifer R. Brown, William G. Wierda, Scott M. Turner, And...> ;Leukemia. 2017 Jan 24
• 37 citations
  Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study
  Marco Montillo, Susan O'Brien, Alessandra Tedeschi, John C. Byrd, Claire Dearden, Devinder Gill, Jennifer R. Brown, Jaqueline C. Barrientos, Stephen P. Mulligan, Richa...> ;Blood Cancer Journal. 2017 Feb 3
• Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells.
  Compagno, M.,Wang, Q.,Pighi, C.,Cheong, T. C.,Meng, F. L.,Poggio, T.,Yeap, L. S.,Karaca, E.,Blasco, R. B.,Langellotto, F.,Ambrogio, C.,Voena, C.,Wiestner, A.,Kasar, S....> ;Nature. 2017 Feb 16
• Ventricular arrhythmias and sudden death in patients taking ibrutinib.
  Lampson, B. L.,Yu, L.,Glynn, R. J.,Barrientos, J. C.,Jacobsen, E. D.,Banerji, V.,Jones, J. A.,Walewska, R.,Savage, K. J.,Michaud, G. F.,Moslehi, J. J.,Brown, J. R.> ;Blood. 2017 Feb 23
• Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phas...
  Zelenetz, A. D.,Barrientos, J. C.,Brown, J. R.,Coiffier, B.,Delgado, J.,Egyed, M.,Ghia, P.,Illés, Á. Á.,Jurczak, W.,Marlton, P.,Montillo, M.,Morschhauser, F.,Pristupa,...> ;Lancet Oncol.. 2017 Feb 01
• 66 citations
  Survival of Del17p CLL Depends on Genomic Complexity and Somatic Mutation.
  Yu, L., Yu, L., Kim, H. T., Kim, H. T., Kasar, S., Kasar, S., Benien, P., Benien, P., Du, W., Du, W., Hoang, K., Hoang, K., Aw, A., Aw, A., Tesar, B., Tesar, B., Impro...> ;Clinical cancer research : an official journal of the American Association for Cancer Research.
• 237 citations
  Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
  Benjamin L. Lampson, Siddha Kasar, Tiago R. Matos, Elizabeth A. Morgan, Laura Z. Rassenti, Matthew S. Davids, David C. Fisher, Arnold S. Freedman, Caron A. Jacobson, P...> ;Blood. 2016 Jul 14
• 177 citations
  Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution.
  Siddha Kasar, Jaegil Kim, R. Improgo, Grace Tiao, Paz Polak, Nicholas J. Haradhvala, Michael S. Lawrence, Adam Kiezun, S. M. Fernandes, Samira Bahl, Carrie Sougnez, St...> ;Nature Communications. 2015 Dec 7
• 23 citations
  Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis
  Shahamat Tauhid, Renxin Chu, Rahul Sasane, Bonnie I. Glanz, Mohit Neema, Jennifer Miller, Gloria Kim, James Signorovitch, Brian C. Healy, Tanuja Chitnis, Howard L. Wei...> ;Journal of Neurology. 2015 Jul 24
• 34 citations
  Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia.
  Hong Wu, Chen Hu, Aoli Wang, Ellen Weisberg, Yongfei Chen, Cai-Hong Yun, Wenchao Wang, Yuan Liu, Xiaochuan Liu, B. Tian, Jinhua Wang, Zheng Zhao, Yanke Liang, Binhua L...> ;Leukemia. 2016 Jan 1
• 43 citations
  Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents.
  Cody Paiva, J C Godbersen, Allison Berger, Jennifer R. Brown, Alexey V. Danilov> ;Cell Death & Disease. 2015 Jul 9
• Join now to see all

Lectures

• Clinical and Biological Indicators of Duvelisib Efficacy in CLL from the Phase 3 DUOTM Study 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018